IGEA collaborates with the renowned Columbia University

The study

A recent work from Dr. Hung et al. from Columbia University in collaboration with IGEA has been published in the peer-reviewed journal “Biotechnology and Bioengineering”.

in this study, the effect of Biophysical Stimulation (I-ONE® therapy) on the structural and functional quality of tissue-engineered cartilage grafts and on post-implant articular environment was assessed.

The results

I-ONE® therapy represents a non-invasive clinical treatment to improve pre-implantation cartilage properties and decrease catabolic activities of pro-inflammatory cytokines post-implantation, leading to good and stable long-term clinical outcomes.

The results show that, in vitro, I-ONE® therapy increases cellular content, extracellular matrix deposition and integration of the engineered constructs.

In focal osteochondral lesions treated with tissue-engineered cartilage grafts, PEMF stimulation promotes the formation of a uniform hyaline-like repair tissue and reduces the levels of pro-inflammatory cytokines.


Studio Columbia University_i-one - Copia.png


Altogether, the results demonstrate the ability of I-ONE® therapy to enhance cartilage repair, through the modulation of the graft integration and the control of the joint environment.


Find out more:



The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2020